Evolution of the Average Target: Coupang, Inc.

Evolution of the Target Price: Coupang, Inc.

Changes in Analyst Recommendations: Coupang, Inc.

ec7a3ad2edface6f436814.dfKFuD5pIuaxtEt2puqvldaszkT9pAE_M-q62jMIbpw.Ib7I9U0BFaTrgQVbw4PCz-XC-Hex_lB8Yd_csGxLP-QAi7zqfAwbn_LOEg~c8a677a28c1edd73b71cb73a13224f1d
UBS Upgrades Coupang to Buy From Neutral MT
Barclays Adjusts Price Target on Coupang to $32 From $25, Maintains Overweight Rating MT
Mizuho Adjusts Coupang's Price Target to $23 From $20, Keeps Neutral Rating MT
Nomura Raises Price Target on Coupang to $26 From $21 on Increased Membership Fee, Keeps Buy Rating MT
Citigroup Upgrades Coupang to Buy From Neutral, Adjusts Price Target to $26 From $19 MT
Morgan Stanley Lifts Price Target on Coupang to $26 From $24 to Reflect WOW Membership Price Increase; Overweight Kept MT
Baemin to Deliver Starbucks Coffee and Food in South Korea MT
Coupang Insider Sold Shares Worth $2,538,210, According to a Recent SEC Filing MT
Barclays Adjusts Price Target on Coupang to $25 From $24, Maintains Overweight Rating MT
UBS Downgrades Coupang to Neutral From Buy, Adjusts Price Target to $18.50 From $26 MT
Barclays Adjusts Price Target on Coupang to $24 From $22, Maintains Overweight Rating MT
BofA Securities Adjusts Coupang's Price Target to $19 From $18, Keeps Neutral Rating MT
BofA Securities Downgrades Coupang to Neutral From Buy MT
Barclays Starts Coupang at Overweight With $20 Price Target MT
New Street Starts Coupang With Buy Rating, Sets Price Target at $25 MT
Mizuho Adjusts Price Target on Coupang to $20 From $22, Maintains Neutral Rating MT
Autonomous Initiates Coupang With Outperform Rating, $22 Price Target MT
HSBC Starts Coupang at Buy With $27.80 Price Target MT
Morgan Stanley Adjusts Coupang's Price Target to $25 From $18, Reiterates Overweight Rating MT
UBS Adjusts Coupang Price Target to $25 From $19, Maintains Buy Rating MT
Mizuho Securities Raises Coupang's Price Target to $22 From $18, Maintains Neutral Rating MT
Mizuho Securities Adjusts Coupang's Price Target to $22 From $18, Maintains Neutral Rating MT
Macquarie Initiates Coupang at Outperform Rating, Sets Price Target at $26 MT
Credit Suisse Upgrades Coupang to Outperform from Neutral, Adjusts Price Target to $19 from $28 MT
Morgan Stanley Initiates Coupang at Overweight, Sets Price Target at $18 MT
More recommendations

Add to a list
Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+12.77%
+17.41%
+50.16%
+12.35%
-17.80%
-22.14%
+0.35%
+25.17%
+27.39%
+77.77%
Average +18.34%
Weighted average by Cap. +17.67%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
24.24USD
Average target price
27.33USD
Spread / Average Target
+12.77%
High Price Target
33.00USD
Spread / Highest target
+36.14%
Low Price Target
18.00USD
Spread / Lowest Target
-25.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Barclays
Mizuho Securities
Nomura
Morgan Stanley
Citigroup
BofA Securities
New Street
Autonomous Research
HSBC
Macquarie
Credit Suisse
Goldman Sachs
Deutsche Bank Securities
Daiwa Securities
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. CPNG Stock
  4. Consensus Coupang, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW